Delivery Order SPE2DB24D2109-SPE2DB24FHVTL

Award Date 6/20/24
Potential Completion Date 6/21/24
Potential Value $51K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency has awarded Amerisourcebergen Drug Corp, through its Corporate Office division, a firm fixed price delivery order contract valued at $9,790.63 to provide BETASERON 0.3 MG KITS. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for Amerisourcebergen Drug Corp...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the supply of BETASERON 0.3 MG KITS to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $19,560.16, is a Firm Fixed Price Delivery Order that runs through October 13, 2023. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical covering a comprehensive range of pharmaceutical products and medical...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The $14,944.37 firm fixed-price delivery order contract is for the supply of the drug BETASERON 0.3 MG KITS and has a performance period through June 21, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary vehicle...
This federal contract award, valued at $16,526.82, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award is for the delivery of Betaseron 0.3 mg kits, a specialty medication, with a completion date of December 22, 2022. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award, valued at $48,992.79, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of BETASERON 0.3 MG KITS, with a completion date of June 7, 2024. The contract has a Firm Fixed Price pricing type and does not have a set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $32,482 Firm Fixed Price Delivery Order contract is for the supply of BETASERON 0.3 MG KITS, a specialty medication. The contract has an ultimate completion date of July 5, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $17,818.42 Firm Fixed Price delivery order is for the supply of BETASERON 0.3 MG KITS, a specialty medication. The contract has a completion date of June 20, 2024 and is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the supply of BETASERON 0.3 MG KITS to the Defense Logistics Agency (DLA). The firm-fixed-price contract, valued at $76,787.49, is a delivery order issued under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which is valued at $999,999,999 and runs through November 2026. This IDC serves as a primary vehicle for Amerisourcebergen to provide a...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $24,326.46, is for the supply of BETASERON 0.3 MG KITS, a specialty pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of January 8, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of Betaseron 0.3 mg kits. The $23,404.72 fixed-price delivery order was issued by the Defense Logistics Agency (DLA) Troop Support Medical. It is not associated with a set-aside designation. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive...
  • SPE2DB24D2109
    Indefinite Delivery Contract
  • SPE2DB24D2109-SPE2DB24FHVTL
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of Betaseron 0.3 mg kits, a pharmaceutical product, to the Defense Logistics Agency (DLA). The firm-fixed-price delivery order has a ceiling value of $51,064.44 and an ultimate completion date of June 21, 2024.

Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with the DLA Troop Support Medical through December 31, 2025. This single-award IDC serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense (DoD) worldwide. The contract does not have a set-aside designation.

Generated 9/19/24, 9:55 AM